ClariTrial | Search Clinical Trials

Explore/HIV Infections

Status

Phase

11,925 results for “HIV Infections”

Page 1 of 795

Completed

Evaluation of a Dose Reduction of Darunavir (400 mg/d) in Virologically Suppressed HIV-1 Patients

Phase 2HIV INFECTION

Darunavir

ANRS, Emerging Infectious Diseases100 participants1 site · FranceCompletes Oct 2016

Compare CT.gov Full analysis →

Completed

Real Risks of the Online World

N/ASexual Health

to develop and validate a scale measuring problematic online dating app (ODA) use in sexual minorities

University of Zurich229 participants1 site · SwitzerlandCompletes Dec 2022

Compare CT.gov Full analysis →

Recruiting

Baricitinib for Reduction of HIV - CNS

Phase 2Human Immunodeficiency Virus

Baricitinib 2 MG Oral TabletPlacebo

William Tyor95 participants2 sites · United StatesCompletes Jan 2028

Compare CT.gov Full analysis →

Completed

Results posted

OPEN Study: Pain Management Treatment Needs Interviews

N/AHIVPeripheral Neuropathy

King's College London26 participants2 sites · United KingdomCompletes Jul 2017

Compare CT.gov Full analysis →

Completed

Effects of MAC Preventive Therapy on Disease-Causing Bacteria in HIV-Infected Patients: A Substudy of CPCRA 048

N/AMycobacterium Avium-intracellulare InfectionHIV InfectionsPneumococcal Infections

National Institute of Allergy and Infectious Diseases (NIAID)326 participants15 sites · United States

Compare CT.gov Full analysis →

Completed

mHealth for ART Adherence by HIV+ African Americans

Phase 2HIV-1-infection

On the Dot Mobile app

Environment and Health Group, Inc.109 participants1 site · United StatesCompletes May 2020

Compare CT.gov Full analysis →

Completed

HIV Reservoir Dynamics After Switching to Dolutegravir in Patients on a PI and 2 NRTI Based Regimen

Phase 4HIV-1

DolutegravirPI2 NRTI+1 more

Hospital Universitari Vall d'Hebron Research Institute44 participants1 site · SpainCompletes Nov 2016

Compare CT.gov Full analysis →

Completed

Results posted

A Study to Evaluate the Efficacy and Safety of Experimental Drugs ABT- 493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 1-6 Infection and Human Immunodeficiency Virus -1 Coinfection (EXPEDITION-2)

Phase 3Hepatitis C Virus InfectionHuman Immunodeficiency Virus InfectionChronic Hepatitis C

ABT-493 coformulated with ABT-530

AbbVie153 participantsCompletes Mar 2017

Compare CT.gov Full analysis →

Completed

HIV Vaccine Designed for HIV Infected Adults Taking Anti-HIV Drugs

Phase 1HIV Infections

Autologous Dendritic Cell HIV Vaccination

National Institute of Allergy and Infectious Diseases (NIAID)18 participants1 site · United States

Compare CT.gov Full analysis →

Withdrawn

Anal Dysplasia Study of Men Who Have Sex With Men Living With HIV

Phase 4Anal DysplasiaHuman Papilloma VirusHIV

imiquimodablative

United States Naval Medical Center, San Diego01 site · United StatesCompletes Dec 2015

Compare CT.gov Full analysis →

Completed

Study to Evaluate the Safety of a Gene and Cell Therapy Product in Participants With HIV That is Well-Controlled on Antiretroviral Therapy

Phase 1HIV

AGT103-T

American Gene Technologies International Inc.7 participants2 sites · United StatesCompletes Aug 2022

Compare CT.gov Full analysis →

UNKNOWN

Impact of Microfinance and Participatory Gender Training for Women in Reducing Intimate Partner Violence

N/AMaltreatment by Spouse or Partner

Participatory gender trainingMicrofinance

London School of Hygiene and Tropical Medicine2,640 participants1 site · TanzaniaCompletes Jul 2019

Compare CT.gov Full analysis →

Completed

Safety of an HIV DNA Vaccine Given to HIV Uninfected Adults

Phase 1HIV Infections

pGA2/JS2 Plasmid DNA Vaccine

National Institute of Allergy and Infectious Diseases (NIAID)30 participants4 sites · United States

Compare CT.gov Full analysis →

Completed

HOPE in Action Trial of HIV+ Deceased Donor Liver Transplants for HIV+ Recipients

N/AHiv

HIVD+/R+

Johns Hopkins University80 participants26 sites · United StatesCompletes Jul 2025

Compare CT.gov Full analysis →

Terminated

A Phase I Safety and Immunogenicity Preventive Vaccine Trial Based on the HIV-1 Tat and V2-deleted Env Proteins (ISS P-002)

Phase 1HIV Infection

HIV-1 Tat/delta-V2 Env combined vaccineHIV-1 delta-V2 Env vaccineHIV-1 Tat vaccine 7.5 microg+1 more

Barbara Ensoli, MD11 participants3 sites · ItalyCompletes Feb 2014

Compare CT.gov Full analysis →

1–15 of 11,925

Explore/HIV Infections

Status

Phase

11,925 results for “HIV Infections”

Page 1 of 795

Completed

Evaluation of a Dose Reduction of Darunavir (400 mg/d) in Virologically Suppressed HIV-1 Patients

Phase 2HIV INFECTION

Darunavir

ANRS, Emerging Infectious Diseases100 participants1 site · FranceCompletes Oct 2016

Compare CT.gov Full analysis →

Completed

Real Risks of the Online World

N/ASexual Health

to develop and validate a scale measuring problematic online dating app (ODA) use in sexual minorities

University of Zurich229 participants1 site · SwitzerlandCompletes Dec 2022

Compare CT.gov Full analysis →

Recruiting

Baricitinib for Reduction of HIV - CNS

Phase 2Human Immunodeficiency Virus

Baricitinib 2 MG Oral TabletPlacebo

William Tyor95 participants2 sites · United StatesCompletes Jan 2028

Compare CT.gov Full analysis →

Completed

Results posted

OPEN Study: Pain Management Treatment Needs Interviews

N/AHIVPeripheral Neuropathy

King's College London26 participants2 sites · United KingdomCompletes Jul 2017

Compare CT.gov Full analysis →

Completed

Effects of MAC Preventive Therapy on Disease-Causing Bacteria in HIV-Infected Patients: A Substudy of CPCRA 048

N/AMycobacterium Avium-intracellulare InfectionHIV InfectionsPneumococcal Infections

National Institute of Allergy and Infectious Diseases (NIAID)326 participants15 sites · United States

Compare CT.gov Full analysis →

Completed

mHealth for ART Adherence by HIV+ African Americans

Phase 2HIV-1-infection

On the Dot Mobile app

Environment and Health Group, Inc.109 participants1 site · United StatesCompletes May 2020

Compare CT.gov Full analysis →

Completed

HIV Reservoir Dynamics After Switching to Dolutegravir in Patients on a PI and 2 NRTI Based Regimen

Phase 4HIV-1

DolutegravirPI2 NRTI+1 more

Hospital Universitari Vall d'Hebron Research Institute44 participants1 site · SpainCompletes Nov 2016

Compare CT.gov Full analysis →

Completed

Results posted

Phase 3Hepatitis C Virus InfectionHuman Immunodeficiency Virus InfectionChronic Hepatitis C

ABT-493 coformulated with ABT-530

AbbVie153 participantsCompletes Mar 2017

Compare CT.gov Full analysis →

Completed

HIV Vaccine Designed for HIV Infected Adults Taking Anti-HIV Drugs

Phase 1HIV Infections

Autologous Dendritic Cell HIV Vaccination

National Institute of Allergy and Infectious Diseases (NIAID)18 participants1 site · United States

Compare CT.gov Full analysis →

Withdrawn

Anal Dysplasia Study of Men Who Have Sex With Men Living With HIV

Phase 4Anal DysplasiaHuman Papilloma VirusHIV

imiquimodablative

United States Naval Medical Center, San Diego01 site · United StatesCompletes Dec 2015

Compare CT.gov Full analysis →

Completed

Study to Evaluate the Safety of a Gene and Cell Therapy Product in Participants With HIV That is Well-Controlled on Antiretroviral Therapy

Phase 1HIV

AGT103-T

American Gene Technologies International Inc.7 participants2 sites · United StatesCompletes Aug 2022

Compare CT.gov Full analysis →

UNKNOWN

Impact of Microfinance and Participatory Gender Training for Women in Reducing Intimate Partner Violence

N/AMaltreatment by Spouse or Partner

Participatory gender trainingMicrofinance

London School of Hygiene and Tropical Medicine2,640 participants1 site · TanzaniaCompletes Jul 2019

Compare CT.gov Full analysis →

Completed

Safety of an HIV DNA Vaccine Given to HIV Uninfected Adults

Phase 1HIV Infections

pGA2/JS2 Plasmid DNA Vaccine

National Institute of Allergy and Infectious Diseases (NIAID)30 participants4 sites · United States

Compare CT.gov Full analysis →

Completed

HOPE in Action Trial of HIV+ Deceased Donor Liver Transplants for HIV+ Recipients

N/AHiv

HIVD+/R+

Johns Hopkins University80 participants26 sites · United StatesCompletes Jul 2025

Compare CT.gov Full analysis →

Terminated

A Phase I Safety and Immunogenicity Preventive Vaccine Trial Based on the HIV-1 Tat and V2-deleted Env Proteins (ISS P-002)

Phase 1HIV Infection

HIV-1 Tat/delta-V2 Env combined vaccineHIV-1 delta-V2 Env vaccineHIV-1 Tat vaccine 7.5 microg+1 more

Barbara Ensoli, MD11 participants3 sites · ItalyCompletes Feb 2014

Compare CT.gov Full analysis →

1–15 of 11,925